Diagnostic and Therapeutic Challenges of Oligosymptomatic Vesicovaginal Fistula in the Complex Case of Endometriosis.
Agnieszka A StrojnyArkadiusz BaranKatarzyna WiejakAnna ScholzRadosław B MaksymPublished in: Clinics and practice (2024)
Endometriosis is a complex condition causing surgical challenges, sometimes leading to urogynecological complications, the diagnosis and treatment of which are not always obvious. We present a case of a 46-year-old woman with a history of severe endometriosis and adenomyosis who developed an oligosymptomatic vesicovaginal fistula (VVF) as a complication of surgery. The patient's medical history included multiple surgeries for endometriosis, a cesarean section, and a laparoscopic hysterectomy. After the excision of the full-thickness infiltration of the urinary bladder, she experienced postoperative bowel obstruction treated by laparotomy. Subsequent urinary complications of bladder healing were eventually recognized as oligosymptomatic VVF. Symptoms of VVFs may vary, making a diagnosis challenging, especially when the lesion is narrow. Imaging techniques such as cystoscopy and cystography are helpful for diagnosis. The treatment options for VVFs range from surgical repair to conservative methods, like bladder catheterization, hormonal therapy, and platelet-rich plasma (PRP) injections, depending on the lesions' size and location. In this case, the patient's VVF was treated with PRP injections, a low-invasive method in urogynecology. PRP, known for its pleiotropic role, is increasingly used in medicine, including gynecology. The patient's fistula closed after 6 weeks from the PRP session, highlighting the potential of this conservative treatment modality.
Keyphrases
- platelet rich plasma
- case report
- spinal cord injury
- healthcare
- high resolution
- minimally invasive
- risk factors
- stem cells
- coronary artery bypass
- ultrasound guided
- high intensity
- optical coherence tomography
- mass spectrometry
- newly diagnosed
- robot assisted
- physical activity
- mesenchymal stem cells
- coronary artery disease
- gestational age
- photodynamic therapy
- polycystic ovary syndrome
- atrial fibrillation
- percutaneous coronary intervention